Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 22: 250-256, 1976;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fyhrquist, F
Right arrow Articles by Stenman, U.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fyhrquist, F
Right arrow Articles by Stenman, U.

Clinical Chemistry, Vol 22, 250-256, Copyright © 1976 by American Association for Clinical Chemistry

Radioimmunoassay of plasma renin activity

F Fyhrquist, P Soveri, L Puutula and UH Stenman

We describe a sensitive, simplified radioimmunoassay method for determination of plasma renin activity. Plasma was acidified to the optimal pH (6.0) of angiotensin l generation with the least possible dilution, by using a single addition of hydrochloric acid and the enzyme inhibitor hydroxyquinoline. Recovery of unlabeled angiotensin l added to plasma was 92-97%; that of monoiodinated angiotensin l exceeded 90%, indicating satisfactory protection from proteolytic enzymes. Plasma constituents interfered little with the radioimmunoassay. Bland values for plasma kept at 0 degrees C were 10.7 +/- 2.3 (mean +/- SD) percent of the activity values for samples kept at +37 degrees C (n equals 63). In the routine setting, 6.25 pg of angiotensin l or 10(-6) Goldblatt units of Standard Human Renin was detected. We report results of plasma renin activity measurements and a comparison with seven renin kits, and with bioassay for plasma renin activity.


The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
S. Leh, O. Vaagnes, S. B. Margolin, B. M. Iversen, and T. Forslund
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats
Nephrol. Dial. Transplant., January 1, 2005; 20(1): 71 - 82.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
N. Uhlenius, O. Vuolteenaho, and I. Tikkanen
Renin-angiotensin blockade improves renal cGMP production via non-AT2-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 233 - 239.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
M. Bojestig, F. H Nystrom, H. J Arnqvist, J. Ludvigsson, and B. E Karlberg
The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 353 - 356.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by the American Association for Clinical Chemistry.